Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice

被引:30
作者
Avraham, Y. [1 ]
Grigoriadis, N. C. [2 ]
Magen, I. [1 ]
Poutahidis, T. [3 ]
Vorobiav, L. [1 ]
Zolotarev, O. [1 ]
Ilan, Y. [4 ]
Mechoulam, R. [5 ]
Berry, E. M. [1 ]
机构
[1] Hadassah Hebrew Univ, Dept Metab & Human Nutr, Braun Sch Publ Hlth, Sch Med, IL-91120 Jerusalem, Israel
[2] Aristotle Univ Thessaloniki, Dept Neurol, AHEPA Univ Hosp, GR-54006 Thessaloniki, Greece
[3] Aristotle Univ Thessaloniki, Dept Pathol, Sch Vet Med, GR-54006 Thessaloniki, Greece
[4] Hadassah Univ Hosp, Liver Unit, IL-91120 Jerusalem, Israel
[5] Hebrew Univ Jerusalem, Dept Med Chem & Nat Prod, Fac Med, Jerusalem, Israel
基金
以色列科学基金会;
关键词
hepatic encephalopathy; fulminant hepatic failure; capsaicin; cannabinoids; thioacetamide; TRPV1; receptors; astrogliosis; catecholamines; serotonin; cognition; CANNABINOID RECEPTOR AGONIST; CLOSED-HEAD INJURY; LIVER-DISEASE; CB2; RECEPTORS; MOUSE-BRAIN; ENDOCANNABINOIDS; ASTROGLIOSIS; SYSTEM; 2-AG; EXPRESSION;
D O I
10.1111/j.1476-5381.2009.00368.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: Hepatic encephalopathy is a neuropsychiatric syndrome caused by liver failure. In view of the effects of cannabinoids in a thioacetamide-induced model of hepatic encephalopathy and liver disease and the beneficial effect of capsaicin (a TRPV1 agonist) in liver disease, we assumed that capsaicin may also affect hepatic encephalopathy. Experimental approach: Fulminant hepatic failure was induced in mice by thioacetamide and 24 h later, the animals were injected with one of the following compound(s): 2-arachidonoylglycerol (CB1, CB2 and TRPV1 receptor agonist); HU308 (CB2 receptor agonist), SR141716A (CB1 receptor antagonist); SR141716A+2-arachidonoylglycerol; SR144528 (CB2 receptor antagonist); capsaicin; and capsazepine (TRPV1 receptor agonist and antagonist respectively). Their neurological effects were evaluated on the basis of activity in the open field, cognitive function in an eight-arm maze and a neurological severity score. The mice were killed 3 or 14 days after thioacetamide administration. 2-arachidonoylglycerol and 5-hydroxytryptamine (5-HT) levels were determined by gas chromatography-mass spectrometry and high-performance liquid chromatography with electrochemical detection, respectively. Results: Capsaicin had a neuroprotective effect in this animal model as shown by the neurological score, activity and cognitive function. The effect of capsaicin was blocked by capsazepine. Thioacetamide induced astrogliosis in the hippocampus and the cerebellum and raised brain 5-hydroxytryptamine levels, which were decreased by capsaicin, SR141716A and HU-308. Thioacetamide lowered brain 2-arachidonoylglycerol levels, an effect reversed by capsaicin. Conclusions: Capsaicin improved both liver and brain dysfunction caused by thioacetamide, suggesting that both the endocannabinoid and the vanilloid systems play important roles in hepatic encephalopathy. Modulation of these systems may have therapeutic value.
引用
收藏
页码:896 / 906
页数:11
相关论文
共 48 条
[1]   The neurosteroid system: an emerging therapeutic target for hepatic encephalopathy [J].
Ahboucha, Samir ;
Butterworth, Roger F. .
METABOLIC BRAIN DISEASE, 2007, 22 (3-4) :291-308
[2]   Guide to receptors and channels (GRAC), 3rd edition [J].
Alexander, Stephen P. H. ;
Mathie, Alistair ;
Peters, John A. .
BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 :S1-S209
[3]   Capsaicin pepper, cancer and ethnicity [J].
Archer, VE ;
Jones, DW .
MEDICAL HYPOTHESES, 2002, 59 (04) :450-457
[4]   Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice [J].
Avraham, Y ;
Israeli, E ;
Gabbay, E ;
Okun, A ;
Zolotarev, O ;
Silberman, I ;
Ganzburg, V ;
Dagon, Y ;
Magen, I ;
Vorobia, L ;
Pappo, O ;
Mechoulam, R ;
Ilan, Y ;
Berry, EM .
NEUROBIOLOGY OF DISEASE, 2006, 21 (01) :237-245
[5]   Behavioral and neurochemical alterations caused by diet restriction - The effect of tyrosine administration in mice [J].
Avraham, Y ;
Bonne, O ;
Berry, EM .
BRAIN RESEARCH, 1996, 732 (1-2) :133-144
[6]   Cannabinoids and Capsaicin Improve Liver Function Following Thioacetamide-Induced Acute Injury in Mice [J].
Avraham, Yosefa ;
Zolotarev, Olga ;
Grigoriadis, Nikolaos C. ;
Pautahidis, Theofilos ;
Magen, Iddo ;
Vorobiav, Lia ;
Zimmer, Andreas ;
Ilan, Yaron ;
Mechoulam, Raphael ;
Berry, Elliot M. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (12) :3047-3056
[7]   2-Arachidonoylglycerol, an endogenous cannabinoid receptor agonist, in various rat tissues during the evolution of experimental cholestatic liver disease [J].
Avraham, Yosefa ;
Magen, Iddo ;
Zolotarev, Olga ;
Vorobiav, Lia ;
Nachmias, Avital ;
Pappo, Orit ;
Ilan, Yaron ;
Berry, Elliot M. ;
Ackerman, Zvi .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2008, 79 (1-2) :35-40
[8]  
BALASINGAM V, 1994, J NEUROSCI, V14, P846
[9]   Endocannabinoids acting at vascular CB, receptors mediate the vasodilated state in advanced liver cirrhosis [J].
Bátkai, S ;
Járat, Z ;
Wagner, JA ;
Goparaju, SK ;
Varga, K ;
Liu, J ;
Wang, L ;
Mirshahi, F ;
Khanolkar, AD ;
Makriyannis, A ;
Urbaschek, R ;
Garcia, N ;
Sanyal, AJ ;
Kunos, G .
NATURE MEDICINE, 2001, 7 (07) :827-832
[10]  
Benito C, 2003, J NEUROSCI, V23, P11136